In order to evaluate and compare the antitumor activity and selectivity of the two types of loaded PDA NPs obtained, MTT assays were carried out with two breast carcinoma cell lines overexpressing HER2 (BT474 and SKBR3) and with stromal cells (HS5 cell line) [16]. Here, ERBB2 is linked to breast carcinoma.